Temasek to invest $150 million in Glenmark Pharma

MUMBAI (Reuters) - Singapore state investment arm Temasek will invest 9.45 billion rupees ($151.39 million) in Glenmark Pharmaceuticals Ltd through its wholly-owned subsidiary Aranda Investments, Glenmark said in a statement on Friday.

Indian drugmaker Glenmark will raise the funds by issuing up to 10.8 million shares on a preferential basis for cash to Aranda, the company said in the statement.

($1 = 62.4226 rupees)

(Reporting by Suvashree Dey Choudhury; editing by Susan Thomas)